Dermatology Billing Example That Protects Revenue

A missed modifier can turn a medically necessary dermatology visit into an avoidable denial. A weak diagnosis pointer can do the same. This dermatology billing example shows how one common office encounter should move from clinical documentation to a clean claim, and where practices routinely leave earned revenue behind.

The point is not to force every encounter into a single formula. Dermatology coding depends on the work performed, the number and type of lesions, pathology findings, payer policy, and the record itself. The point is to make the revenue logic visible before a claim goes out the door.

Anatomy of a Dermatology Billing Example

Consider an established patient who presents with two separate concerns. First, the patient reports a new, changing pigmented lesion on the left shoulder. Second, the provider evaluates and treats four clinically diagnosed actinic keratoses on the forehead.

The provider performs a medically necessary, separately identifiable evaluation of the changing shoulder lesion, including history, examination, risk discussion, and biopsy planning. The provider then takes a tangential biopsy of the shoulder lesion and destroys four premalignant forehead lesions with cryotherapy.

A representative claim may look like this:

| Service | Illustrative CPT coding | Diagnosis linkage | Why it belongs on the claim | |---|---|---|---| | Separate E/M service | 99213-25 | Changing lesion diagnosis, as documented | The evaluation went beyond the usual work inherent in performing the procedures. | | Tangential biopsy, first lesion | 11102 | Uncertain or unspecified skin neoplasm diagnosis, as supported by documentation | The provider sampled the changing shoulder lesion for pathology. | | Destruction, first premalignant lesion | 17000 | L57.0 | The first actinic keratosis was treated. | | Destruction, additional premalignant lesions | 17003 x3 | L57.0 | Three additional actinic keratoses were treated. |

This is illustrative, not a substitute for current payer edits, CPT guidance, or a review of the medical record. A payer may require a distinct procedural service modifier when biopsy and destruction codes are billed together for different lesions or sites. The correct modifier placement depends on the edit and the payer's policy. Billing teams should verify the edit rather than reflexively adding modifier 59 to every procedural claim.

That distinction matters. A modifier is not a revenue button. It is a statement that the documentation must prove.

The clinical note drives the claim

The note needs to identify the lesions separately. "Biopsy performed and AKs frozen" is not enough to defend the claim when an auditor or payer asks questions. The record should establish the shoulder lesion's location, clinical concern, size when relevant, biopsy technique, specimen handling, and the reason pathology is needed. It should separately identify the forehead actinic keratoses, the number treated, and the destruction method.

For the E/M service, the note must show work that is significant and separately identifiable from the procedure. A brief examination immediately before a biopsy does not automatically support 99213-25. If the provider evaluated the changing lesion, assessed risk, considered management options, and performed work beyond the normal pre-procedure assessment, the documentation must say so plainly.

Where Dermatology Claims Break Down

Dermatology offices do not usually lose revenue because their clinicians failed to provide care. They lose it because the clinical story, charge capture, claim edits, and follow-up workflow are disconnected. That fragmentation creates denials that should never have reached the payer.

Diagnosis coding before pathology

For the shoulder lesion, the practice should not code a confirmed skin malignancy before pathology establishes that diagnosis. The diagnosis on the biopsy claim should reflect the provider's documented clinical assessment and the applicable coding guidance, such as a neoplasm of uncertain behavior when that diagnosis is clinically documented and supported. In other circumstances, an unspecified neoplasm diagnosis may be more appropriate.

This is not a minor technicality. Coding a definitive cancer diagnosis before confirmation can create compliance exposure. Coding an overly vague diagnosis when the note supports more specificity can weaken medical necessity. The billing team must match the claim to what the provider knew and documented on the date of service.

When pathology returns, the practice may need to update its clinical record and use the confirmed diagnosis for subsequent treatment. The pathology result does not rewrite what was known on the original biopsy date.

Underbilling lesion count

The destruction codes in this example reflect four actinic keratoses: 17000 for the first lesion and 17003 for each additional lesion within the applicable range. If the provider treated four lesions but documented only "AKs treated," the billing team has no defensible basis to report the additional units.

The opposite error is just as costly. Reporting extra units without a documented count invites recoupment. The right answer is not aggressive coding or conservative coding. It is precise coding supported by a precise note.

Modifier 25 used as a default

Modifier 25 is one of the most abused modifiers in outpatient medicine. In dermatology, it is often appended whenever an office visit and procedure occur on the same day. That is not the standard.

The E/M must be substantial enough to stand on its own, separate from the usual evaluation required to perform the procedure. If the encounter was limited to confirming the lesion and performing the planned biopsy, an E/M code may not be warranted. If the provider addressed a distinct problem, performed a meaningful evaluation, and documented medical decision-making beyond the procedure, modifier 25 may be appropriate.

Practices that bill it automatically create denial risk. Practices that avoid it even when clearly supported give away payment for legitimate physician work. Both failures come from weak process control.

The Revenue Impact Goes Beyond One Claim

A denied $90 or $150 line item may look insignificant in isolation. Across a busy dermatology practice, repeated mistakes in lesion counts, E/M documentation, diagnosis linkage, and modifier use become a material drag on collections. They also consume staff time through rework, appeals, patient balance confusion, and delayed posting.

The bigger problem is timing. A claim that is corrected two months later is not equivalent to a clean claim paid on the first pass. Delayed reimbursement strains cash flow and obscures the practice's true financial performance. When staff are forced to chase preventable denials, they are not confirming benefits, collecting patient responsibility, obtaining authorizations, or supporting patients.

That is why billing cannot operate as a downstream data-entry function. It needs access to the documentation, payer rules, charge capture logic, and denial intelligence that shape the claim before submission.

How a Practice Should Work This Claim

A disciplined workflow starts before the patient leaves. The provider documents each condition, lesion location, lesion count, procedure technique, and the clinical basis for services performed. The charge capture process then translates that record into candidate codes without guessing at missing facts.

Before claim submission, the billing team validates diagnosis-to-procedure linkage, units, modifiers, National Correct Coding Initiative edits, payer-specific requirements, and patient coverage details. If an edit flags a potential bundle, the team checks whether the note supports a distinct service and whether the payer recognizes the relevant modifier. If not, the claim is corrected before it becomes a denial.

After submission, payment posting must be specific. A generic adjustment code tells leadership almost nothing. The practice should know whether a reduction occurred because of a contractual allowance, missing modifier, medical-necessity edit, diagnosis mismatch, timely filing issue, or payer processing error. Those categories reveal whether the fix belongs in provider education, front-desk workflow, charge review, or appeals.

CareVixis approaches this as a revenue operation, not a claim-submission task. We collect, investigate the leakage, and connect billing performance to the systems that influence it, including documentation workflow, patient communication, authorization activity, and reporting. If the same denial appears every week, it is not an isolated denial. It is a process failure that needs to be stopped at the source.

When This Dermatology Billing Example Changes

Real encounters often become more complex than the example above. A biopsy can involve a different technique. A lesion may be excised rather than sampled. A pathology result may lead to a later excision, Mohs surgery, repair, or referral. Cosmetic services may be excluded from insurance billing even when performed in the same practice. Medicare, commercial payers, and Medicare Advantage plans can apply different coverage and edit rules.

The coding framework changes with the clinical facts, but the operating principle does not: document the work clearly, code only what the record supports, validate payer edits before submission, and attack denials while appeal rights are still open.

A clean dermatology claim is not created by software alone or by a coder working in isolation. It is created when clinical care and revenue operations tell the same, defensible story, so the practice gets paid for the care it already earned.

Ready to strengthen your practice revenue? Read about how CareVixis approaches revenue cycle management for independent practices, or explore our full library of practice operations guides.